Paysign (NASDAQ:PAYS) CEO Mark Newcomer Sells 50,000 Shares of Stock

Paysign, Inc. (NASDAQ:PAYS) CEO Mark Newcomer sold 50,000 shares of the company’s stock in a transaction on Friday, October 9th. The shares were sold at an average price of $15.34, for a total value of $767,000.00. Following the completion of the transaction, the chief executive officer owned 9,113,002 shares of the company’s stock, valued at $139,793,450.68. This trade represents a 0.55% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Newcomer also recently made the following trade(s):

• On Thursday, August 6th, Mark Newcomer sold 150,000 shares of Paysign stock. The shares were sold at an average price of $11.88, for a total value of $1,782,000.00.
• On Wednesday, July 29th, Mark Newcomer sold 50,000 shares of Paysign stock. The shares were sold at an average price of $9.38, for a total value of $469,000.00.

Paysign Price Performance

NASDAQ PAYS opened at $15.16 on Thursday. The stock has a market capitalization of $855.96 million, a price-to-earnings ratio of 58.31 and a beta of 0.83. Paysign, Inc. has a one year low of $3.08 and a one year high of $15.62. The business’s fifty day moving average is $13.34 and its 200-day moving average is $9.37.

Paysign (NASDAQ:PAYS) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.11 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.05. Paysign had a net margin of 15.67% and a return on equity of 30.13%. The company had revenue of $28.25 million for the quarter, compared to the consensus estimate of $26.36 million. Paysign has set its FY 2026 guidance at 0.350-0.370 EPS and its Q3 2026 guidance at 0.090-0.100 EPS. Research analysts expect that Paysign, Inc. will post 0.58 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research firms recently commented on PAYS. Barrington Research set a $15.00 price objective on shares of Paysign in a report on Tuesday, August 11th. DA Davidson upped their price target on Paysign from $12.00 to $15.00 and gave the company a “buy” rating in a research report on Wednesday, September 30th. Lake Street Capital upped their price target on Paysign from $13.00 to $15.00 and gave the company a “buy” rating in a research report on Tuesday, September 15th. Weiss Ratings raised shares of Paysign from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, October 8th. Finally, Wall Street Zen lowered shares of Paysign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. Three investment analysts have rated the stock with a Buy rating. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $15.00.

Institutional Inflows and Outflows

A number of hedge funds have recently made changes to their positions in the company. BlackRock Inc. bought a new position in Paysign in the 2nd quarter worth about $25,219,000. Punch & Associates Investment Management Inc. purchased a new stake in shares of Paysign in the 2nd quarter valued at about $16,983,000. Renaissance Technologies LLC raised its holdings in shares of Paysign by 17.4% in the 1st quarter. Renaissance Technologies LLC now owns 1,531,072 shares of the company’s stock valued at $9,033,000 after acquiring an additional 227,300 shares in the last quarter. AWM Investment Company Inc. bought a new stake in shares of Paysign during the 2nd quarter valued at about $6,560,000. Finally, Dimensional Fund Advisors LP boosted its position in shares of Paysign by 16.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 575,619 shares of the company’s stock valued at $3,396,000 after acquiring an additional 82,736 shares during the last quarter. 25.89% of the stock is currently owned by hedge funds and other institutional investors.

Paysign Company Profile

Paysign, Inc (NASDAQ: PAYS) provides prepaid payment and financial technology solutions, with a focus on healthcare, pharmaceutical and other specialized markets. Its platform supports the issuance and management of prepaid cards, digital payments, account services and related payment-processing activities.

The company’s healthcare offerings include patient assistance and copay programs that help pharmaceutical manufacturers distribute financial support to eligible patients. Paysign also provides payment and card solutions for plasma collection centers, including programs used to compensate plasma donors.